---
stable_id: R-HSA-6803240
display_name: Homo- or heterodimerization of RAF downstream of mutant RAS
species: Homo sapiens
summary: Similar to the WT pathway, activation of RAF downstream of oncogenic RAS
  depends on homo- or heterodimerization of RAF, although the importance of RAF proteins
  varies among cancer types (Dumaz et al, 2006; Heidorn et al, 2010; Blasco et al,
  2011; Karreth et al, 2011; Eser et al, 2013; Heidorn et al, 2010; Poulikakos et
  al, 2010; Hatzivassiliou et al, 2010; reviewed in Lito et al, 2013). A notable exception
  to this requirement for RAF dimerization is BRAF V600E, which is RAS-independent
  and constitutively active as a monomer (Roring et al, 2012; Brummer et al, 2006;
  Freeman et al, 2013; Garnett et al, 2005).
---

# Homo- or heterodimerization of RAF downstream of mutant RAS
**Reactome ID:** [R-HSA-6803240](https://reactome.org/content/detail/R-HSA-6803240)
**Species:** Homo sapiens

## Summary

Similar to the WT pathway, activation of RAF downstream of oncogenic RAS depends on homo- or heterodimerization of RAF, although the importance of RAF proteins varies among cancer types (Dumaz et al, 2006; Heidorn et al, 2010; Blasco et al, 2011; Karreth et al, 2011; Eser et al, 2013; Heidorn et al, 2010; Poulikakos et al, 2010; Hatzivassiliou et al, 2010; reviewed in Lito et al, 2013). A notable exception to this requirement for RAF dimerization is BRAF V600E, which is RAS-independent and constitutively active as a monomer (Roring et al, 2012; Brummer et al, 2006; Freeman et al, 2013; Garnett et al, 2005).
